Drug reference
Prophylaxis of asthma ▶BY INHALATION OF AEROSOL ▶Child 12–17 years: 160 micrograms once daily; reduced to 80 micrograms once daily, if control maintained; increased if necessary up to 320 micrograms twice daily, in severe asthma ▶Adult: 160 micrograms once daily; reduced to 80 micrograms once daily, if control maintained; increased if necessary up to 320 micrograms twice daily, in severe asthma
PDF page 298
MHRA/CHM ADVICE: PRESSURISED METERED DOSE INHALERS (PMDI): RISK OF AIRWAY OBSTRUCTION FROM ASPIRATION OF LOOSE OBJECTS (JULY 2018) See Respiratory system, drug delivery p. 249.
PDF page 298
→Appendix 1: corticosteroids
PDF page 298
Cushing’s syndrome
PDF page 298
Manufacturer advises caution in severe impairment (risk of increased exposure, no information available).
PDF page 298
There can be variation in the licensing of different medicines containing the same drug. Pressurised inhalation CAUTIONARY AND ADVISORY LABELS 8 ▶Alvesco (AstraZeneca UK Ltd) Ciclesonide 80 microgram per 1 dose Alvesco 80 inhaler | 120 dose P £32.83 DT = £32.83 Ciclesonide 160 microgram per 1 dose Alvesco 160 inhaler | 60 dose P £19.31 DT = £19.31 | 120 dose P £38.62 DT = £38.62 eiiii F 270
PDF page 298
Patients or carers should be given advice on how to administer ciclesonide aerosol inhaler.
PDF page 298
160 micrograms once daily; reduced to
First-line fragment. Read the complete Indications and Dose section above.
PDF page 298
